A Resolution recognizing the month of June 2025 as "Lipedema Awareness Month" in Pennsylvania.
Take action
Record your position on this measure.
Create an account to take a stance, submit a written position, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Overview
This resolution aims to raise awareness about lipedema, a chronic condition primarily affecting women, during June 2025 in Pennsylvania. It recognizes the challenges associated with diagnosing and managing lipedema, including its often misdiagnosis as other conditions. The resolution encourages further research and support for individuals living with lipedema and highlights the importance of public awareness to improve diagnosis and treatment options.
Key provisions
- Designates June 2025 as "Lipedema Awareness Month" in Pennsylvania.
- Recognizes the specific characteristics of lipedema, including its symmetrical presentation and impact on women.
- Acknowledges the difficulties in diagnosing lipedema due to a lack of definitive tests.
- Encourages continued research into the causes, genetics, and epidemiology of lipedema.
- Promotes awareness of the condition's potential impact on mental health and quality of life.
- Highlights available care and treatment options for managing lipedema symptoms.
Who is affected
- Women
- Individuals with lipedema
- Healthcare providers
Notable changes
- None – This is a resolution recognizing an awareness month, not a legislative change.
Bill text
Read the latest version inline or switch to a previous version.
Document of record
- Version
- Pn 0147 Html
- Published
- Not published in the source record
This version is published only as a document. Open the viewer to read it here, or download the file.
Sponsors
Official sponsors from legislative records.
2 on record
Primary sponsor
Cosponsor
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours